Sonographic features of inflammatory breast cancer

Seminars in Roentgenology

Volumn 46, Issue 4, 2011, Pages 275-279

  Le Petross, Huong ^a   Uppendahl, Locke ^a,b   Stafford, Jason ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST BIOPSY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; ECHOMAMMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFLAMMATORY BREAST CANCER; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, MAMMARY;

EID: 82455172226     PISSN: 0037198X     EISSN: 15584658     Source Type: Journal    
DOI: 10.1053/j.ro.2011.04.003     Document Type: Article

References (28)

1. Greene F.L., Page D.L., Fritz A., et al. Breast, in American Journal of Clinical Cancer, Cancer Staging Manual 2002, 255-281. Springer-Verlag, New York, NY. 6.
2. Bell C: A System of Operative Surgery. vol 2. Hartford, CT, Hale and Hosmer, 1814.
3. Lee B., Tannenbaum N. Inflammatory carcinoma of the breast: A report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet 1924, 39:580-595.
4. Taylor G., Meltzer A. "Inflammatory carcinoma" of the breast. Am J Cancer 1938, 33:33-49.
5. Levine P.H., Veneroso C. The epidemiology of inflammatory breast cancer. Semin Oncol 2008, 35:11-16.
6. Levine P.H., Steinhorn S.C., Ries L.G., et al. Inflammatory breast cancer: The experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst 1985, 74:291-297.
7. Chang S., Parker S.L., Pham T., et al. Inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer 1998, 82:2366-2372.
8. Anderson W.F., Chu K.C., Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: Distinct clinicopathologic entities?. J Clin Oncol 2003, 21:2254-2259.
9. Anderson W.F., Chu K.C., Chang S., et al. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 2004, 13:1128-1135.
10. Wingo P.A., Jamison P.M., Young J.L., et al. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes Control 2004, 15:321-328.
11. Hance K.W., Anderson W.F., Devesa S.S., et al. Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005, 97:966-975.
12. Cristofanilli M., Valero V., Buzdar A.U., et al. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease. Cancer 2007, 110:1436-1444.
13. Ulger H., Erdogan N., Kumanlioglu S., et al. Effect of age, breast size, menopausal and hormonal status on mammographic skin thickness. Skin Res Technol 2003, 9:284-289.
14. American College of Radiology (ACR): ACR BI-RADS®-ultrasound, in ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA, American College of Radiology, et al:.
15. Carkaci S., Macapinlac H.A., Cristofanilli M., et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: Preliminary data. J Nucl Med 2009, 50:231-238.
16. Yang W.T., Le-Petross H.T., Macapinlac H., et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008, 109:417-426.
17. Caumo F., Gaioni M.B., Bonetti F., et al. Occult inflammatory breast cancer: Review of clinical, mammographic, US and pathologic signs. Radiol Med 2005, 109:308-320.
18. Lee K.W., Chung S.Y., Yang I., et al. Inflammatory breast cancer: Imaging findings. Clin Imaging 2005, 29:22-25.
19. Günhan-Bilgen I., Ustün E.E., Memiş A. Inflammatory breast carcinoma: Mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 2002, 223:829-838.
20. Belli P., Costantini M., Romani M., et al. Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays 2002, 27:299-305.
21. Sobrino-Mota V., Lagarejos-Bernardo S., Varela-Mezquita B., et al. Unusual sonographic findings in a case of atypical medullary inflammatory carcinoma of the breast. J Clin Ultrasound 2008, 36:166-168.
22. Chow C.K. Imaging in inflammatory breast carcinoma. Breast Dis 2005-06, 22:45-54.
23. Bonnier P., Charpin C., Lejeune C., et al. Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?. Int J Cancer 1995, 62:382-385.
24. Pamilo M., Soiva M., Lavast E.M. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 1989, 8:115-120.
25. Somlo G., Frnakel P., Chow W., et al. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. J Clin Oncol 2004, 22:1839-1848.
26. Yang C.H., Cristofanilli M. Systemic treatments for inflammatory breast cancer. Breast Dis 2005, 22:55-65. -06.
27. Buzdar A.U., Singletary S.E., Booser D.J., et al. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience. Surg Oncol Clin N Am 1995, 4:715-734.
28. Oksuzoǧlu B., Vural M., Abali H., et al. Blood flow indices by Doppler ultrasonography vary with neoadjuvant chemotherapy but are not related to plasma VEGF levels in locally advanced breast cancer. Oncology 2006, 71:185-189.